Elevance Health Inc.
NYSE:ELVMedical - Healthcare Plans
-$3.45 today
- Market cap
- $86.60B
- Beta
- 0.68
- P/E (TTM)
- 16.3
- EPS (TTM)
- $23.78
- Dividend yield
- 1.77%
Volume 1.91M
Average 1.68M
ELV Total Current Liabilities
All obligations due within one year.
Elevance Health Inc.NYSE: ELV
Total Current Liabilities · Q3 FY2026 · quarter ended Sep 2026
Total current liabilities rises 158.1% from a year ago
Total current liabilities stood at $46.66B at the end of Q3 FY2026, up 158.1% from a year earlier and up 42.4% from the prior quarter. Over 3 fiscal years it compounded at +2.3% a year.
Context
- Total current liabilities amounted to 36.5% of total assets at the end of Q3 FY2026, up 21.8 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +158.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 19.96B USD
- Year-over-year change
- +2.8%
- 4-year CAGR
- +6.5%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 19.96B | +2.8% |
| FY2024 | 2024-12-31 | 19.42B | -0.7% |
| FY2023 | 2023-12-31 | 19.55B | +4.8% |
| FY2022 | 2022-12-31 | 18.65B | +20.2% |
| FY2021 | 2021-12-31 | 15.53B | — |
Total Current Liabilities vs competitors
How ELV compares with its peers on the latest reported figures
- ELV's Sep 2026 total current liabilities of $46.66B is the 4th highest of the 9 companies compared; the peer median is $32.41B.
- Its year-over-year change of +158.1% is the highest of 9, against a peer median of +5.5%.
- Total current liabilities amounts to 36.5% of total assets for ELV, versus a peer median of 44.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $115.84B | +0.3% | +8.8% | 37.0% | |
| Jun 2026 | $87.04B | -7.6% | +8.5% | 34.3% | |
| Sep 2026 | $56.03B | -0.7% | +11.0% | 35.5% | |
| Sep 2026 | $46.66B | +158.1% | +2.3% | 36.5% | |
| Jun 2026 | $40.76B | +10.8% | -9.0% | 49.1% | |
| Sep 2026 | $24.05B | +132.3% | -3.9% | 42.0% | |
| Jun 2026 | $8.69B | +78.6% | +17.9% | 77.4% | |
| Sep 2026 | $7.39B | -1.2% | +2.5% | 47.2% | |
| Mar 2026 | $655.97M | +43.5% | +27.5% | 52.0% | |
| Peer median (excluding ELV) | $32.41B | +5.5% | +8.6% | 44.6% | |
Competitors are the stored peer set for ELV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4.88B | 7.39B | 6.53B | 8.29B | 9.49B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 9.69B | 11.75B | 12.46B | 13.06B | 15.24B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 14.57B | 19.13B | 18.99B | 21.34B | 24.73B |
| Property, Plant & Equipment (Net) | 4.55B | 4.92B | 4.94B | 5.22B | 5.13B |
| Goodwill | 24.23B | 24.38B | 25.32B | 28.28B | 28.34B |
| Intangible Assets | 10.62B | 10.32B | 10.27B | 12.09B | 11.2B |
| Long-term Investments | 34.01B | 33.34B | 36.83B | 37.18B | 38.58B |
| Tax Assets | 103M | 137M | 228M | 206M | 298M |
| Other Non-current Assets | 9.39B | 10.53B | 12.36B | 12.57B | 13.21B |
| Total Non-current Assets | 82.89B | 83.62B | 89.94B | 95.55B | 96.77B |
| Total Assets | 97.46B | 102.76B | 108.93B | 116.89B | 121.49B |
| Account Payables | 13.52B | 15.6B | 16.11B | 15.75B | 17.08B |
| Short-term Debt | 2.01B | 1.95B | 2.04B | 2.17B | 1.38B |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 1.11B | 1.4B | 1.51B | 1.49B |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 15.53B | 18.65B | 19.55B | 19.42B | 19.96B |
| Long-term Debt | 22.02B | 23.1B | 23.93B | 29.88B | 31.33B |
| Deferred Tax Liabilities | 2.81B | 2.02B | 1.97B | 2.15B | 2.11B |
| Deferred Revenue (Non-current) | 1.15B | 1.11B | 0 | 0 | 0 |
| Other Non-current Liabilities | 18.96B | 20.79B | 23.39B | 23.36B | 23.55B |
| Total Non-current Liabilities | 45.81B | 47.77B | 49.97B | 56.04B | 57.51B |
| Total Liabilities | 61.33B | 66.43B | 69.52B | 75.46B | 77.47B |
| Common Stock | 2M | 2M | 2M | 2M | 2M |
| Retained Earnings | 27.09B | 29.65B | 31.75B | 33.55B | 35.39B |
| Accumulated OCI | (178M) | (2.49B) | (1.31B) | (1.15B) | (451M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 68M | 87M | 99M | 111M | 144M |
| Total Equity | 36.13B | 36.33B | 39.41B | 41.43B | 44.03B |
| Total Debt | 24.89B | 25.8B | 26.65B | 32.7B | 33.24B |
| Net Debt | 20.01B | 18.41B | 20.13B | 24.41B | 23.74B |
Elevance Health Inc.
NYSE:ELV
Intrinsic Alpha fair value
Locked
Current Price
$400.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.